Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management
Top Cited Papers
Open Access
- 24 January 2017
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Endocrinology
Abstract
Type 2 diabetes mellitus (T2DM) is a global pandemic, as evident from the global cartographic picture of diabetes by the International Diabetes Federation (http://www.diabetesatlas.org/). Diabetes mellitus (DM) is a chronic, progressive, incompletely understood metabolic condition chiefly characterized by hyperglycemia. Either impaired insulin secretion, resistance to tissue actions of insulin or a combination of both are thought to be the commonest reasons contributing to the pathophysiology of T2DM, a spectrum of disease originally arising from tissue insulin resistance and gradually progressing to a state characterized by complete loss of secretory activity of the beta-cells of the pancreas. T2DM is a major contributor to the very large rise in the rate of non-communicable diseases affecting developed as well as developing nations. In this mini-review, we endeavor to outline the current management principles, including the spectrum of medications that are currently used for pharmacologic management, for lowering the elevated blood glucose in T2DM.Keywords
This publication has 40 references indexed in Scilit:
- The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 Inhibitors in Adults with Type 2 Diabetes MellitusPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
- An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in miceNature Medicine, 2013
- Prediabetes: a high-risk state for diabetes developmentThe Lancet, 2012
- Cellular and molecular mechanisms of metformin: an overviewClinical Science, 2011
- From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes MellitusDiabetes, 2009
- Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of TherapyDiabetes Care, 2009
- Recommendations for Management of Diabetes During RamadanDiabetes Care, 2005
- The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitusJCI Insight, 1999
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Effects of Dietary Fiber and Carbohydrate on Glucose and Lipoprotein Metabolism in Diabetic PatientsDiabetes Care, 1991